Aeluma's CEO sold at $13.35. The street still says $25.
Aeluma's board cut the quorum for its November 19 annual meeting to a third of the shares and will shrink to four seats, weeks after $1.5 million of insider sales. The stock opened October 12 at $11.40.
Vincent Jiang · 3 min read
One-third of the shares can now hold the meeting
Six days after fixing the record date for its November 19 annual meeting, the board of Aeluma−6.32% — Aeluma, down 6.32 percent today, a Goleta, Calif., semiconductor company that grows photonics on large-diameter silicon wafers and is now pitching AI datacom, rewrote its bylaws: the quorum for stockholder meetings dropped from a majority of voting power to one-third 1. The definitive proxy filed September 30 shrinks the board to four seats after that meeting, from five, with director Craig Ensley not standing again 2.
Of 19,314,923 shares outstanding on the September 23 record date, the presence of 6,438,308 now makes a meeting 2. The same filing concedes that its three-class staggered board "may delay or prevent a change of our management or a change in control" 2.
The AI pivot arrives with dilution attached
The governance retreat lands mid-repositioning. On September 15, Aeluma signed Sumitomo Chemical Advanced Technologies to grow photonics wafers for AI datacom at a Phoenix plant 3, and a July letter of intent promises up to $30 million from the Commerce Department's CHIPS R&D office 4.
The letter carries a term its headlines skipped: on final documents, Aeluma would issue equity securities to Commerce equal in value to the award 4, the structure under which Commerce took 1% of the chip foundry GlobalFoundries for $300 million 5.
Underneath the pivot, the June quarter booked revenue of $0.58 million against $1.32 million a year earlier, a $4.0 million net loss, and the third straight quarterly revenue decline 67. Cash stands at $56.0 million, helped by $20.1 million from selling 830,484 shares at an average $24.87 6.
Revenue has fallen for three straight quarters, from $1.39M to $0.58M
Data
| Revenue | |
|---|---|
| Q3 '23 | $0.03M |
| Q4 '23 | $0.26M |
| Q1 '24 | $0.34M |
| Q2 '24 | $0.28M |
| Q3 '24 | $0.48M |
| Q4 '24 | $1.61M |
| Q1 '25 | $1.25M |
| Q2 '25 | $1.32M |
| Q3 '25 | $1.39M |
| Q4 '25 | $1.27M |
| Q1 '26 | $1.22M |
| Q2 '26 | $0.58M |
Aeluma issued stock at $24.87; its CEO sold at $13.35; the target says $25
- Estimate
Data
| Value | |
|---|---|
| 52-week high | $31.79 |
| Analyst 12-month target (estimate) | $25 |
| ATM issuance, June quarter | $24.87 |
| CEO sale, Sept 21 | $13.35 |
| Oct 12 open | $11.4 |
The people closest sold below the target
Chief executive Jonathan Klamkin sold 100,000 shares at an average $13.35 on September 21, $1.34 million under a pre-arranged 10b5-1 plan, keeping 1,226,995 shares 8. Director Steven DenBaars sold 12,500 at $13.84 in August 8; institutions including Wedbush and Bank of America had opened positions in the second quarter, before those sales 8.
The finance chief did better on paper: Christopher Stewart's first-year package was valued at $3.46 million against Klamkin's $690,000 2, in a fiscal year when stock-compensation expense of $4.5 million outran $4.46 million of revenue 6.
From $11.40 to $25
Shares popped 7% to $13.42 on the Sumitomo morning 9; they opened October 12 at $11.40, about a dollar above their 52-week low 8. Five analysts still average a $25.00 target, on three buys, one strong buy and one sell 8.
The bridge rests on AI-datacom engineering contracts still being negotiated, none signed 6, and it runs two dated tests: the November 19 meeting, which convenes under the new one-third quorum, and the CHIPS definitive documents, which would price the equity owed to Commerce if the award closes 4.
Deepdive
AI-generated from this story and its cited sources. Not investment advice.
